{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:42:32Z","timestamp":1761619352927},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jhsa.2008.05.028","type":"journal-article","created":{"date-parts":[[2008,8,31]],"date-time":"2008-08-31T05:18:37Z","timestamp":1220159917000},"page":"1211-1214","source":"Crossref","is-referenced-by-count":6,"title":["Current Management of Onychomycosis"],"prefix":"10.1016","volume":"33","author":[{"given":"Kara S.","family":"Nunley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhsa.2008.05.028_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mjd.2000.104794","article-title":"Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","article-title":"Effect of onychomycosis on quality of life","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib3","series-title":"Dermatology","first-page":"965","article-title":"Biology of hair and nails","author":"Paus","year":"2008"},{"issue":"Suppl 39","key":"10.1016\/j.jhsa.2008.05.028_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0733-8635(03)00027-5","article-title":"The use of oral antifungal agents to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jhsa.2008.05.028_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail onychomycosis: current and future treatment options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jhsa.2008.05.028_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1089-3261(03)00021-7","article-title":"Hepatotoxicity of antibiotics and antifungals","volume":"7","author":"Thiim","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhsa.2008.05.028_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.det.2006.03.010","article-title":"Therapies for onychomycosis: a review","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jhsa.2008.05.028_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0733-8635(05)70460-5","article-title":"Oral antifungal drug interactions","volume":"15","author":"Katz","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jhsa.2008.05.028_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2003.05728.x","article-title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","volume":"150","author":"Gupta","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0378-6323.16619","article-title":"An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis","volume":"71","author":"Mishra","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl 4","key":"10.1016\/j.jhsa.2008.05.028_bib13","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.37056","article-title":"An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis","volume":"73","author":"Jaiswal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","volume":"157","author":"Baran","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jhsa.2008.05.028_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002512-200724040-00003","article-title":"Onychomycosis in the elderly: drug treatment options","volume":"24","author":"Loo","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jhsa.2008.05.028_bib17","series-title":"Comprehensive dermatologic drug therapy","first-page":"75","article-title":"Systemic antifungal agents","author":"Gupta","year":"2008"},{"key":"10.1016\/j.jhsa.2008.05.028_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.12.012","article-title":"Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis- and Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial","volume":"4","author":"Tavakkol","year":"2006","journal-title":"Am J Geriatr Pharmacother"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036350230800436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036350230800436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T00:50:50Z","timestamp":1545785450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036350230800436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S036350230800436X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2008.05.028","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}